Status:
COMPLETED
Calcium Dobesilate Versus Coasting for Prevention of Ovarian Hyperstimulation Syndrome
Lead Sponsor:
khalid abd aziz mohamed
Conditions:
Infertility
Eligibility:
FEMALE
23-45 years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to compare the effect of oral Calcium Dobesilate versus costing in the prevention of ovarian hyperstimulation syndrome (OHSS) in high-risk women underwent intracytoplasmic...
Detailed Description
Two hundred and twenty women at risk of ovarian hyperstimulation syndrome during ICSI cycles will be randomly scheduled into two equal groups. In group A, (Calcium Dobesilate group), 1 cap / 8 hs Doxi...
Eligibility Criteria
Inclusion
- Infertile women undergoing intracytoplasmic sperm injection or polycystic ovarian syndrome (PCO) with one of the following:
- Presence of more than 20 follicles by ultrasound
- E2 more than 3000 pg/ml
- Retrieval of more than 15 follicles
Exclusion
- None
Key Trial Info
Start Date :
June 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT02290002
Start Date
June 1 2014
End Date
December 1 2016
Last Update
February 14 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Benha univesity hospital
Banhā, Egypt, 13518